DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20214953

Reactive infectious mucocutaneous eruptions associated with SARS-CoV-2 infection

Shaji Thomas John, Gayathri K., Rizwana P., Abhay M. Martin

Abstract


Several dermatological manifestations are described in COVID-19. A 3-year-old boy presented with fever, painful oral ulcers with COVID-19 infection. A diagnosis of reactive infectious mucocutaneous eruptions (RIME) was made. He was worked up for the usual causes of RIME but were all negative. His severe acute respiratory syndrome corona virus-2 immunoglobulin M (SARS-CoV-2 IgM) was positive and he was managed with Intravenous hydrocortisone with which he improved dramatically. RIME might be the first/only manifestation of COVID-19 and it should be kept in mind.


Keywords


COVID-19, Reactive infectious mucocutaneous eruptions

Full Text:

PDF

References


Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1):8.

Santosh ABR, Muddana K. Viral infections of oral cavity. J Family Med Prim Care. 2020;9:36-42.

Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Desai SR, et al. The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020;83(4):1118-29.

Amorim Dos Santos J, Normando AGC, Carvalho da Silva RL, De Paula RM, Cembranel AC, Santos-Silva AR, et al. Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations? Int J Infect Dis. 2020;97:326-8.

Ramien ML, Bruckner AL. Mucocutaneous eruptions in acutely ill pediatric patients—think of mycoplasma pneumoniae (and other infections) first. JAMA Dermatol. 2020;156(2):124-5.

Song A, Nicholson C, Maguiness S. Recurrent reactive infectious mucocutaneous eruption (RIME) in two adolescents triggered by several distinct pathogens including SARS-CoV-2 and influenza A. Pediatr Dermatol. 2021;00:1-4.